Bioventus Share Price Today
(NASDAQ: BVS)

Name: Bioventus Share Price Today (NASDAQ: BVS) - Bioventus Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Bioventus share price is $7.65 & ₹653.75 as on 26 Apr 2025, 2.30 'hrs' IST

$7.65

▲

-0.08

(-1.03%)

Market is closed - opens 7 PM, 28 Apr 2025

View live Bioventus share price in Dollar and Rupees. Guide to invest in Bioventus stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bioventus, along with analyst recommendations, forecasts, and comprehensive financials.

Bioventus share price movements

Today's Low: $7.51
Today's High: $7.74
$7.65
1.87%
Downside
Day's Volatility :2.95%
Upside
1.1%
52 Weeks Low: $3.90
52 Weeks High: $14.38
$7.65
49.02%
Downside
52 Weeks Volatility :72.88%
Upside
46.8%

Bioventus (BVS) Returns

Period	Bioventus Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-23.16%	-4.8%	0.0%
6 Months	-40.81%	-7.5%	0.0%
1 Year	94.22%	-1.8%	0.0%
3 Years	-38.26%	2.1%	-9.5%

Bioventus (BVS) Key Statistics

in dollars & INR

Previous Close	$7.73
Open	$7.73
Today's High	$7.735
Today's Low	$7.506919
Market Capitalization	$502.7M
Today's Volume	$391.8K
52 Week High	$14.38
52 Week Low	$3.9
Revenue TTM	$573.3M
EBITDA	$59.0M
Earnings Per Share (EPS)	$-0.52
Profit Margin	-5.85%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-21.55%

How to invest in Bioventus Stock (BVS) from India?

It is very easy for Indian residents to invest directly in Bioventus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioventus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bioventus or BVS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioventus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioventus shares which would translate to 0.112 fractional shares of Bioventus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bioventus, in just a few clicks!

Returns in Bioventus (BVS) for Indian investors in Rupees

The Bioventus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Bioventus investment value today

Current value as on today

₹1,90,519

Returns

₹90,519

(+90.52%)

Returns from Bioventus Stock

₹87,961 (+87.96%)

Dollar Returns

₹2,558 (+2.56%)

Indian investors sentiment towards Bioventus (BVS)

725%

Period: Mar 26, 2025 to Apr 25, 2025. Change in 30 Days versus previous period

Search interest for Bioventus Stock from India on INDmoney has increased by 725% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Bioventus

Essex Woodlands Health Ventures
19.68%
Juniper Investment Co, LLC
10.49%
Nantahala Capital Management, LLC
6.09%
BlackRock Inc
4.22%
Vanguard Group Inc
3.72%
Driehaus Capital Management LLC
1.69%

Analyst Recommendation on Bioventus

Rating

Trend

Buy

71%Buy

14%Hold

14%Sell

Based on 7 Wall street analysts offering stock ratings for Bioventus(by analysts ranked 0 to 5 stars)

Analyst Forecast on Bioventus Stock (BVS)

What analysts predicted

Upside of 96.08%

Target:

$15.00

Current:

$7.65

Insights on Bioventus Stock (Ticker Symbol: BVS)

Price Movement
In the last 1 year, BVS stock has moved up by 89.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 138.96M → 153.64M (in $), with an average increase of 9.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -23.99M → -156.0K (in $), with an average increase of 1694.8% per quarter
BVS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 126.8% return, outperforming this stock by 167.6%

Bioventus Technicals Summary

Sell

Neutral

Buy

Bioventus is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bioventus (BVS) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bioventus Inc	-15.24%	-40.81%	94.22%	-38.26%	-59.76%
Medtronic Plc	-5.26%	-6.95%	5.72%	-20.94%	-16.34%
Edwards Lifesciences Corp.	5.53%	9.65%	-13.07%	-31.58%	2.51%
Boston Scientific Corp.	0.34%	19.33%	38.23%	134.88%	173.35%
Stryker Corporation	-1.77%	1.42%	7.58%	44.91%	88.09%
Abbott Laboratories	-1.5%	13.42%	20.32%	10.85%	36.26%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bioventus Inc	9.44	NA	2.14	0.66	-0.22	0.03	NA	2.25
Medtronic Plc	25.7	25.7	1.44	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.57	31.57	4.24	2.46	0.17	0.08	NA	16.99
Boston Scientific Corp.	73.82	73.82	1.94	2.91	0.09	0.05	NA	14.76
Stryker Corporation	44.86	44.86	2.03	13.46	0.15	0.07	0.01	54.1
Abbott Laboratories	16.96	16.96	4.17	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bioventus Inc	Buy	$502.7M	-59.76%	9.44	-5.85%
Medtronic Plc	Buy	$108.1B	-16.34%	25.7	12.83%
Edwards Lifesciences Corp.	Buy	$44.0B	2.51%	31.57	75.71%
Boston Scientific Corp.	Buy	$149.6B	173.35%	73.82	11.58%
Stryker Corporation	Buy	$136.3B	88.09%	44.86	13.25%
Abbott Laboratories	Buy	$224.4B	36.26%	16.96	31.89%

About Bioventus

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise of various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides nexus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company's restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system; and Talisman pulse generator and receiver for peripheral nerve stimulation. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.

Organization	Bioventus
Employees	930
CEO	Mr. Mike Crowe B.S., M.B.A.
Industry	Healthcare

Management People of Bioventus

Name	Title
Mr. Mike Crowe B.S., M.B.A.	Senior Vice President of Operations
Mr. David Crawford	Vice President of Investor Relations & Treasurer
Ms. Katrina J. Church J.D.	Senior VP & Chief Compliance Officer
Ms. Helen Leupold	Senior VP & Chief Human Resources Officer
Mr. Dave Venner	Senior VP & GM of Surgical

Important FAQs about investing in BVS Stock from India :

What is Bioventus share price today?

Bioventus share price today stands at $7.65, Open: $7.73 ; Previous Close: $7.73 ; High: $7.74 ; Low: $7.51 ; 52 Week High: $14.38 ; 52 Week Low: $3.90.

The stock opens at $7.73, after a previous close of $7.73. The stock reached a daily high of $7.74 and a low of $7.51, with a 52-week high of $14.38 and a 52-week low of $3.90.

Can Indians buy Bioventus shares?

Yes, Indians can invest in the Bioventus (BVS) from India.

With INDmoney, you can buy Bioventus at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bioventus at zero transaction cost.

How can I buy Bioventus shares from India?

It is very easy to buy Bioventus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioventus (BVS) be purchased?

Yes, you can buy fractional shares of Bioventus with INDmoney app.

What are the documents required to start investing in Bioventus stocks?

To start investing in Bioventus, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.